Growth Metrics

Forte Biosciences (FBRX) Current Assets (2016 - 2020)

Historic Current Assets for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $21.6 million.

  • Forte Biosciences' Current Assets fell 6369.51% to $21.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was $21.6 million, marking a year-over-year decrease of 6369.51%. This contributed to the annual value of $7.5 million for FY2019, which is 9232.11% down from last year.
  • Per Forte Biosciences' latest filing, its Current Assets stood at $21.6 million for Q3 2020, which was down 6369.51% from $28.1 million recorded in Q2 2020.
  • Forte Biosciences' 5-year Current Assets high stood at $109.6 million for Q2 2017, and its period low was $7.5 million during Q4 2019.
  • In the last 5 years, Forte Biosciences' Current Assets had a median value of $75.0 million in 2018 and averaged $62.0 million.
  • In the last 5 years, Forte Biosciences' Current Assets skyrocketed by 17919.35% in 2017 and then plummeted by 9232.11% in 2019.
  • Forte Biosciences' Current Assets (Quarter) stood at $32.5 million in 2016, then soared by 179.19% to $90.6 million in 2017, then rose by 7.86% to $97.7 million in 2018, then tumbled by 92.32% to $7.5 million in 2019, then skyrocketed by 188.0% to $21.6 million in 2020.
  • Its last three reported values are $21.6 million in Q3 2020, $28.1 million for Q2 2020, and $14.5 million during Q1 2020.